like ci without esrx deal would prefer differ
acquisit see potenti compani hit accret guidanc deal close
comfort move point servic plan dual track vertic
integr approach via jv partner provid expand telemedicin allow
compani way provid in-hom on-demand care littl capit invest
concern come scalabl speed expans program believ peer
move faster space
ep vs consensu driven stronger expect
revenu growth medic cost control consolid
consensu estim commerci vs
govern vs sg
consensu estim total enrol
estim revenu estim consensu
cfo net incom day claim payabl day
ep guidanc rais vs new
estim commerci guidanc lower
govern lower
reflect ci industri lead cost trend manag revenu growth guidanc
rais enrol growth held steadi
segment healthcar earn expect
global health global supplement benefit
unchang group disabl life
roll estim ep growth
incorpor revenu growth healthcar growth
esrx deal vote sharehold et deal synergi
reiter potenti synergi ci/esrx deal show confid propos
hh rule chang either go combin compani gener
synergi regardless chang rule california insur commission
urg doj block aet/cv deal yesterday lay reason vertic
integr strategi could anti competit believ similar claim made
toward ci/esrx deal given overlap vertic integr strategi
see comment major influenc doj decis block approv
deal
fourth-largest health insur focu non-risk product
price close august
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
earn comparison guidanc tabl
reiter ow rate lower pt
pt base
ep
rais ep estim reflect
strong quarter sustain confid
ci industri lead cost trend
manag lower multipl
base lesser capit deploy
opportun follow
announc esrx acquisit
compani data pjc estim
page
incom statement pjc estq/qq/q y/yy/i act vs estimate variancevar fom con total analysi pjc estq/qq/q y/yy/i act vs estimate variancevar fom con global supplement disabl life pjc estq/qq/q y/yy/i act vs estimate variancevar fom con us guarante hc corpor ci
thousand except per share
premium fee
net earn common sharehold
non oper item net tax
compani report piper jaffray co current disclosur inform compani found http //www piperjaffray com/researchdisclosur
